Is VGIP11 worth it? Analysis of Valora CRI Índice de Preços FII

Recommendation: ACCUMULATE · Rating 6.8/10

Analysis and recommendation

VGIP11 is a portfolio of 50 real estate loans (known as CRIs — real-estate-backed receivables certificates), 99.4% of which are indexed to the IPCA: the fund lends money to shopping malls, developers, and logistics warehouses and passes the interest on to you every month, free of income tax. Valora Investimentos, an asset manager with R$ 13 billion under management, actively manages the portfolio — in January 2026, it swapped lower-yielding CRIs for ones with higher coupons (raising the average to IPCA+8.44%), increasing portfolio yield ahead of interest rate cuts. The unit price dropped from ~R$ 100 (2023) to the current ~R$ 79, a common movement for the segment during a high-interest-rate cycle — there is no reported delinquency in the portfolio. Caution: the monthly distribution fluctuates significantly — ranging from R$ 0.64 to R$ 1.98 over the past 12 months, because the passed-through IPCA is always from two months prior (when inflation rises in February, you receive more in April). The average of R$ 0.92/month (dividend yield of ~14% at the current price) is the honest figure for income planning. The current price represents a 13% discount to the fund's intrinsic net assets — a P/BV of 0.87 means you pay R$ 79 for every R$ 90 of net assets. It suits investors seeking inflation protection who accept month-to-month income variation; it is not suitable for those who require a fixed monthly payout. Verdict: ACCUMULATE — a good inflation hedge with an entry discount, provided you look at the annual average rather than each month's figure.

Investment thesis

VGIP11 is a credit FII 99.4% indexed to the IPCA with 49 CRIs diversified across 9 real estate segments. Average coupon of 8.44%, average yield of 10.19%, and duration of 3.6 years — proven carry robustness. 100% compliance declared by Valora management, with active rotation: in January 2026, it sold IPCA+7% CRIs and bought 4 with IPCA+9.6%. A P/BV of 0.90 offers a 10% margin of safety relative to book value. The 10.7% dividend yield over the past 12 months is attractive for inflation protection, but DPU fluctuates wildly month to month (R$ 0.43 to R$ 1.98) due to the M-2 IPCA lag — investors seeking predictable income will be frustrated.

Who it's for

  • Investors seeking pure inflation protection (99.4% IPCA+)
  • Moderate risk profile willing to accept real estate credit exposure
  • Those seeking monthly income above inflation with income tax exemption
  • Investors who value proven active management (Valora regularly rotates its portfolio)
  • Those who understand and tolerate month-to-month DPU volatility in exchange for an inflation hedge

Who it's not for

  • Those seeking stable monthly dividends (M-2 IPCA causes extreme volatility)
  • Investors who do not tolerate performance fees
  • Ultra-conservative profile who prefer Tesouro IPCA+ exclusively
  • Those seeking exposure to CDI or fixed rates (the fund is 99.4% IPCA+)
  • Those who do not accept unrated CRIs (84% of the portfolio lacks an international rating)

Points of attention and risks

Patria consolidation could create a mega-competitor

Highly volatile DPU (M-2 lag)

Performance relative to IMA-B5+IPCA

Concentration in Campus Matarazzo

Is VGIP11 trustworthy?

Our current reading of VGIP11 is ACCUMULATE, with a score of 6.8/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.

Valora IPCA+ at the largest discount in the top bucket (P/BV of 0.81) and a dividend yield of 13.0%, but with the most volatile DPU in the group (R$ 0.64 to R$ 1.98 due to the M-2 lag). Pátria's potential consolidation of IPCA+ funds and the concentration in Campus Matarazzo (10.7%) add uncertainty. The wide discount partially offsets the trajectory risk.

Risks that don't show up in VGIP11's fact sheet

FIP Matarazzo concentration (10.7% of net assets)

CRIs 451S + 545S finance the same development (Campus Matarazzo, Bela Vista/SP). IPCA+9.5% coupon and 326% collateral coverage — but any construction delays or retail commercialization issues would impact the portfolio's largest position.

84% without a rating agency assignment

Only 11 of the 49 CRIs hold an S&P/Fitch/Moody's rating. The other 38 are monitored internally by Valora. In the event of a sudden management shift or reputational issue at Valora, investors lack a second evaluation source.

Recycling of R$ 51M in 2026

CRI Choice (R$ 36M maturing 08/04/2026) and CRI AR Terrenos (R$ 15M maturing 09/29/2026) total ~5.4% of net assets. Management must find substitutes with an equivalent coupon (~IPCA+9%) in a falling Selic environment — a real operational challenge.

Sensitivity to negative IPCA readings

IPCA M-2 CRIs ('positive variation only' accounts for 74% of the IPCA portfolio) offset negative months with positive ones. However, '99.4% Positive Variation Only + 25.9% full IPCA' means that if the IPCA runs negative for 3+ consecutive months, a temporary mismatch occurs in the DPU.

Performance fee in extraordinary cycles

20% on the excess over IPCA+IMA-B5 (currently IPCA+8.69%). If the portfolio's average coupon (8.44%) falls below the benchmark + accrued IPCA, no performance fee is charged. However, during rotations generating expressive capital gains (such as 2025: R$ 22.9M), the performance fee can consume 4-5% of the extraordinary gain.

Exposure risk to hospitality via Mabu

CRI Mabu 402S (8.94% of net assets, IPCA+9.75%) is the largest individual position. Rede Mabu is strong in Southern Brazil, but hospitality is cyclical — recessions directly impact time-sharing. A 175% collateral coverage on the CRI mitigates risk, but hotel execution is complex.

Conclusion

VGIP11 is a leading credit FII (Brazilian REIT-style fund) with 99.4% of its portfolio indexed to the IPCA (IPCA, Brazil's official inflation index), R$ 1.07 billion in net assets, and a portfolio of 49 CRIs with a 100% current payment track record. An average coupon of 8.44%, an average yield of 10.19%, and a duration of 3.6 years demonstrate a robust carry profile. The 8.7% real return (IPCA + 8.7% p.a.) over the last 12 months is consistent with the fund's history since 2020.

Valora's active management is a genuine differentiator, not just marketing. In January 2026, it sold R$ 92.5M in CRIs yielding IPCA + 7% (Tecnisa 397S and São Gonçalo 179E) and reinvested R$ 82.1M into 4 CRIs with an average coupon of IPCA + 9.6%, boosting the portfolio carry by 0.3 to 0.5 percentage points ahead of the rate-cutting cycle. In 2025, portfolio rotations generated R$ 22.9M in capital gains — proof of an engaged management team.

However, pay attention to the volatile DPU (distribution per unit): over the past 12 months, it ranged from R$ 0.43 (Aug/25) to R$ 1.98 (May/25) — a 360% swing. This is structural and tied to the 2-month lagged IPCA indexer (IPCA M-2). In months with low inflation readings (Jan-Feb/26: 0.18%-0.33%), the DPU drops to R$ 0.64–R$ 0.74. In months capturing accumulated inflation spikes, the DPU jumps. Investors seeking predictable monthly income like a bank CD will be disappointed — VGIP11 is an inflation hedge, not a fixed-income instrument.

A P/BV of 0.90 offers a 10% margin of safety against the book value of R$ 91.18, backed by healthy diversification (an HHI of 390 across 49 CRIs and 9 segments). The central fair value is calculated at R$ 88 — the current quote of R$ 82.33 sits 6.9% below that level, offering a real margin for medium-term investors.

Frequently asked questions

Is VGIP11 good? Is it worth investing?

Current recommendation: ACCUMULATE. Rating 6.8/10. VGIP11 is a portfolio of 50 real estate loans (known as CRIs — real-estate-backed receivables certificates), 99.4% of which are indexed to the IPCA: the fund lends money to shopping malls, developers, and logistics warehouses and passes the interest on to you every month, free…

VGIP11: buy or sell?

Our current read on VGIP11 is “ACCUMULATE”. Rating 6.8/10. Assess it against your risk profile and the points of attention listed above.

What are VGIP11's risks?

The main points of attention for Valora CRI Índice de Preços FII include: Patria consolidation could create a mega-competitor; Highly volatile DPU (M-2 lag); Performance relative to IMA-B5+IPCA; Concentration in Campus Matarazzo.

Who is VGIP11 suitable for?

VGIP11 is suitable for: Investors seeking pure inflation protection (99.4% IPCA+) Moderate risk profile willing to accept real estate credit exposure Those seeking monthly income above inflation with income tax exemption